Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00072319
Status:
COMPLETED
Last Update Posted:
2013-03-04
First Post:
2003-11-04
Brief Title:
Neoadjuvant or Adjuvant Epirubicin Cyclophosphamide and Paclitaxel in Treating Women With Stage I Stage II or Stage III Breast Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center